ASR Vermogensbeheer N.V. Buys New Stake in Henry Schein, Inc. (NASDAQ:HSIC)

ASR Vermogensbeheer N.V. bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 4,636 shares of the company's stock, valued at approximately $318,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Palestra Capital Management LLC acquired a new stake in Henry Schein in the 4th quarter valued at approximately $182,988,000. Fiduciary Management Inc. WI increased its holdings in Henry Schein by 7.2% in the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after purchasing an additional 167,990 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Henry Schein by 15.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,137,549 shares of the company's stock valued at $147,920,000 after purchasing an additional 279,507 shares during the last quarter. Steadfast Capital Management LP increased its holdings in Henry Schein by 254.2% in the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company's stock valued at $113,336,000 after purchasing an additional 1,175,408 shares during the last quarter. Finally, Hudson Bay Capital Management LP increased its holdings in Henry Schein by 102.1% in the 4th quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company's stock valued at $101,378,000 after purchasing an additional 740,007 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on HSIC. JPMorgan Chase & Co. dropped their target price on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a report on Thursday. Baird R W downgraded shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Barrington Research dropped their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research note on Wednesday, August 6th. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research note on Wednesday, August 6th. Finally, Wells Fargo & Company dropped their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Nine investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $75.58.

Henry Schein Price Performance

Henry Schein stock opened at $65.94 on Monday. The stock has a market cap of $8.00 billion, a P/E ratio of 21.27, a price-to-earnings-growth ratio of 2.17 and a beta of 0.81. The company has a fifty day simple moving average of $71.07 and a 200-day simple moving average of $71.06. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. Henry Schein's revenue for the quarter was up 3.3% on a year-over-year basis. During the same period last year, the firm posted $1.23 earnings per share. Equities analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.